Gazyva-话题@MedSci - 梅斯（MedSci）

#Gazyva#

4篇内容 | 1113人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1460402, encodeId=516014604022c, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, objectType=article, longId=179673, objectId=1fca1e96732d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fca1e96732d, replyNumber=0, likeNumber=74, createdTime=2019-09-20, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fca1e96732d, moduleTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1fca1e96732d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460401, encodeId=edd014604012d, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, objectType=article, longId=60416, objectId=efc1604161b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efc1604161b, replyNumber=0, likeNumber=50, createdTime=2015-12-10, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efc1604161b, moduleTitle=ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=efc1604161b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460400, encodeId=9273146040092, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=失而复得，罗氏白血病药物Gazyvaro重获NICE批准, objectType=article, longId=43573, objectId=74ac435e3f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ac435e3f6, replyNumber=0, likeNumber=0, createdTime=2014-12-06, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ac435e3f6, moduleTitle=失而复得，罗氏白血病药物Gazyvaro重获NICE批准, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=74ac435e3f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1460399, encodeId=a9f11460399db, content=<a href='/topic/show?id=9948e87080' target=_blank style='color:#2F92EE;'>#Gazyva#</a>, objectTitle=FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病, objectType=article, longId=26357, objectId=0aed2635ee7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0aed2635ee7, replyNumber=0, likeNumber=90, createdTime=2013-11-09, rootId=0, userName=cy0326, userId=77aa6313597, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0aed2635ee7, moduleTitle=FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0aed2635ee7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Gazyva

2020-05-29

cy0326 (审核中...)

前往app查看评论内容

#Gazyva#

FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定

2019-09-20

cy0326 (审核中...)

前往app查看评论内容

#Gazyva#

ASH 2015：Gazyva联合苯丁酸氮芥一线治疗CLL后4年内无需治疗

2015-12-10

cy0326 (审核中...)

前往app查看评论内容

#Gazyva#

失而复得，罗氏白血病药物Gazyvaro重获NICE批准

2014-12-06

cy0326 (审核中...)

前往app查看评论内容

#Gazyva#

FDA批准Gazyva与苯丁酸氮芥联合治疗慢性淋巴细胞白血病

2013-11-09

科室
- - 订阅+
  - 更多科室
工具
服务